Sally Stabler
Concepts (824)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin B 12 Deficiency | 62 | 2020 | 81 | 7.030 |
Why?
| | Vitamin B 12 | 60 | 2020 | 128 | 6.020 |
Why?
| | Homocysteine | 79 | 2024 | 156 | 5.400 |
Why?
| | Homocystinuria | 18 | 2024 | 71 | 3.800 |
Why?
| | Folic Acid | 52 | 2024 | 186 | 3.270 |
Why?
| | Methionine | 40 | 2021 | 160 | 3.110 |
Why?
| | Methylmalonic Acid | 54 | 2017 | 65 | 3.020 |
Why?
| | Folic Acid Deficiency | 27 | 2021 | 49 | 2.790 |
Why?
| | Cystathionine beta-Synthase | 17 | 2024 | 71 | 2.220 |
Why?
| | Liver | 29 | 2024 | 1943 | 2.100 |
Why?
| | Betaine | 19 | 2024 | 73 | 1.990 |
Why?
| | S-Adenosylmethionine | 22 | 2020 | 54 | 1.810 |
Why?
| | S-Adenosylhomocysteine | 17 | 2020 | 24 | 1.780 |
Why?
| | Hyperhomocysteinemia | 14 | 2020 | 27 | 1.650 |
Why?
| | Vitamin B Complex | 10 | 2020 | 44 | 1.580 |
Why?
| | Amino Acids, Sulfur | 4 | 2020 | 7 | 1.420 |
Why?
| | Nutritional Status | 8 | 2020 | 350 | 1.070 |
Why?
| | Cysteine | 12 | 2020 | 204 | 1.070 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 3 | 2019 | 11 | 0.990 |
Why?
| | Taurine | 4 | 2019 | 46 | 0.990 |
Why?
| | Tetrahydrofolates | 2 | 2024 | 18 | 0.960 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.890 |
Why?
| | Sulfur | 3 | 2020 | 58 | 0.790 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 9 | 2021 | 36 | 0.750 |
Why?
| | Oxidation-Reduction | 5 | 2024 | 1060 | 0.750 |
Why?
| | Choline | 11 | 2017 | 127 | 0.730 |
Why?
| | Dietary Supplements | 15 | 2020 | 561 | 0.710 |
Why?
| | Sulfur Compounds | 1 | 2020 | 7 | 0.690 |
Why?
| | Methionine Adenosyltransferase | 6 | 2020 | 9 | 0.690 |
Why?
| | Metabolic Diseases | 1 | 2020 | 108 | 0.630 |
Why?
| | Anemia | 6 | 2014 | 170 | 0.620 |
Why?
| | Glycine Hydroxymethyltransferase | 6 | 2021 | 16 | 0.560 |
Why?
| | Anemia, Megaloblastic | 6 | 2020 | 9 | 0.520 |
Why?
| | Methylation | 12 | 2020 | 230 | 0.520 |
Why?
| | Cystathionine | 14 | 2012 | 24 | 0.500 |
Why?
| | Diet | 12 | 2013 | 1278 | 0.480 |
Why?
| | Animals | 66 | 2024 | 36940 | 0.480 |
Why?
| | Humans | 163 | 2021 | 137585 | 0.470 |
Why?
| | Female | 119 | 2024 | 73304 | 0.460 |
Why?
| | Iron, Dietary | 1 | 2014 | 22 | 0.450 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2014 | 58 | 0.450 |
Why?
| | Aged, 80 and over | 34 | 2017 | 7635 | 0.440 |
Why?
| | Adenosylhomocysteinase | 5 | 2021 | 10 | 0.440 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 4 | 2017 | 17 | 0.430 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 4 | 2015 | 24 | 0.430 |
Why?
| | Gas Chromatography-Mass Spectrometry | 16 | 2020 | 132 | 0.420 |
Why?
| | Mice | 34 | 2024 | 17787 | 0.420 |
Why?
| | Glutathione | 8 | 2020 | 356 | 0.420 |
Why?
| | Male | 103 | 2024 | 67762 | 0.400 |
Why?
| | Cognition Disorders | 5 | 2011 | 496 | 0.380 |
Why?
| | Neural Tube Defects | 4 | 2020 | 64 | 0.380 |
Why?
| | Disease Models, Animal | 15 | 2021 | 4295 | 0.370 |
Why?
| | Aged | 59 | 2017 | 23961 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 11 | 2020 | 2057 | 0.350 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 4 | 2017 | 8 | 0.350 |
Why?
| | Isoenzymes | 5 | 2012 | 304 | 0.350 |
Why?
| | Biomarkers | 19 | 2020 | 4149 | 0.340 |
Why?
| | Frail Elderly | 2 | 2010 | 131 | 0.340 |
Why?
| | Metabolism, Inborn Errors | 5 | 2020 | 41 | 0.330 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 44 | 0.330 |
Why?
| | Receptors, Cell Surface | 3 | 2015 | 385 | 0.330 |
Why?
| | Methylmalonyl-CoA Mutase | 9 | 2017 | 10 | 0.330 |
Why?
| | Uracil | 4 | 2021 | 31 | 0.330 |
Why?
| | Carbon | 3 | 2024 | 216 | 0.320 |
Why?
| | Cystathionine gamma-Lyase | 4 | 2020 | 13 | 0.320 |
Why?
| | Thrombosis | 2 | 2011 | 371 | 0.320 |
Why?
| | Thioctic Acid | 1 | 2009 | 11 | 0.320 |
Why?
| | Middle Aged | 57 | 2020 | 33479 | 0.310 |
Why?
| | Abortion, Spontaneous | 1 | 2009 | 105 | 0.310 |
Why?
| | Adult | 69 | 2020 | 37929 | 0.300 |
Why?
| | Intestinal Absorption | 3 | 2013 | 102 | 0.300 |
Why?
| | Vitamin B Deficiency | 1 | 2008 | 1 | 0.290 |
Why?
| | Propionibacterium | 1 | 2008 | 2 | 0.290 |
Why?
| | Eubacterium | 1 | 2008 | 3 | 0.290 |
Why?
| | Up-Regulation | 3 | 2017 | 843 | 0.290 |
Why?
| | DNA | 8 | 2020 | 1459 | 0.290 |
Why?
| | Pregnancy | 17 | 2020 | 6763 | 0.270 |
Why?
| | Feces | 3 | 2019 | 484 | 0.270 |
Why?
| | Acyl Coenzyme A | 5 | 2006 | 31 | 0.270 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 5757 | 0.270 |
Why?
| | Malnutrition | 1 | 2008 | 83 | 0.270 |
Why?
| | Prevalence | 13 | 2017 | 2734 | 0.260 |
Why?
| | Dietary Services | 2 | 2005 | 2 | 0.260 |
Why?
| | Corrinoids | 2 | 2019 | 7 | 0.250 |
Why?
| | Nutrition Assessment | 1 | 2006 | 92 | 0.250 |
Why?
| | Sulfhydryl Compounds | 4 | 2018 | 189 | 0.250 |
Why?
| | Amino Acids | 6 | 2020 | 497 | 0.250 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2021 | 283 | 0.240 |
Why?
| | Antioxidants | 1 | 2009 | 584 | 0.240 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 7 | 2017 | 18 | 0.240 |
Why?
| | Transcobalamins | 3 | 2017 | 4 | 0.230 |
Why?
| | Human papillomavirus 16 | 2 | 2018 | 35 | 0.230 |
Why?
| | Disease Progression | 3 | 2011 | 2757 | 0.230 |
Why?
| | Mice, Knockout | 10 | 2020 | 3015 | 0.230 |
Why?
| | Administration, Oral | 8 | 2019 | 816 | 0.220 |
Why?
| | Vitamin B 6 | 2 | 2003 | 10 | 0.220 |
Why?
| | Geriatrics | 2 | 2003 | 98 | 0.220 |
Why?
| | Brain Diseases | 2 | 2020 | 141 | 0.220 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2015 | 176 | 0.210 |
Why?
| | Mutation | 11 | 2017 | 3958 | 0.210 |
Why?
| | Rumen | 3 | 2014 | 7 | 0.210 |
Why?
| | Food, Fortified | 4 | 2010 | 42 | 0.210 |
Why?
| | Gestational Age | 3 | 2020 | 910 | 0.210 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 1043 | 0.210 |
Why?
| | Rats | 18 | 2016 | 5647 | 0.200 |
Why?
| | Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2012 | 2 | 0.200 |
Why?
| | Apolipoproteins E | 5 | 2013 | 83 | 0.200 |
Why?
| | Neonatal Screening | 2 | 2007 | 169 | 0.190 |
Why?
| | Uterine Artery | 2 | 2020 | 79 | 0.190 |
Why?
| | Fetal Blood | 5 | 2013 | 327 | 0.190 |
Why?
| | Hearing Loss | 1 | 2006 | 221 | 0.190 |
Why?
| | Ferredoxin-NADP Reductase | 3 | 2012 | 3 | 0.190 |
Why?
| | Heterozygote | 4 | 2015 | 293 | 0.190 |
Why?
| | Cohort Studies | 11 | 2020 | 5742 | 0.180 |
Why?
| | Nutrition Surveys | 3 | 2011 | 266 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 2 | 2015 | 180 | 0.180 |
Why?
| | Mice, Transgenic | 8 | 2014 | 2167 | 0.180 |
Why?
| | Body Mass Index | 1 | 2009 | 2389 | 0.180 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 433 | 0.180 |
Why?
| | Lactation | 4 | 2015 | 181 | 0.180 |
Why?
| | Sulfites | 1 | 2020 | 7 | 0.170 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2011 | 93 | 0.170 |
Why?
| | Cattle | 3 | 2014 | 984 | 0.170 |
Why?
| | Aging | 7 | 2010 | 1864 | 0.170 |
Why?
| | Formate-Tetrahydrofolate Ligase | 2 | 2012 | 2 | 0.170 |
Why?
| | Polyamines | 1 | 2021 | 40 | 0.170 |
Why?
| | Anemia, Pernicious | 3 | 2013 | 9 | 0.170 |
Why?
| | Fetal Growth Retardation | 2 | 2020 | 565 | 0.170 |
Why?
| | Brazil | 4 | 2009 | 167 | 0.170 |
Why?
| | Global Health | 1 | 2004 | 386 | 0.170 |
Why?
| | Animals, Newborn | 3 | 2007 | 844 | 0.170 |
Why?
| | Erythrocytes | 8 | 2011 | 700 | 0.160 |
Why?
| | Carrier Proteins | 3 | 2014 | 771 | 0.160 |
Why?
| | Virus Integration | 2 | 2018 | 71 | 0.160 |
Why?
| | Aminobutyrates | 2 | 2018 | 35 | 0.160 |
Why?
| | Reference Values | 12 | 2010 | 816 | 0.160 |
Why?
| | Polymorphism, Genetic | 4 | 2015 | 660 | 0.160 |
Why?
| | Genetic Diseases, Inborn | 2 | 2004 | 44 | 0.160 |
Why?
| | Caenorhabditis elegans | 2 | 2017 | 306 | 0.160 |
Why?
| | Umbilical Arteries | 1 | 2020 | 55 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.160 |
Why?
| | Depressive Disorder | 2 | 2000 | 379 | 0.160 |
Why?
| | Gene Rearrangement | 1 | 2020 | 150 | 0.160 |
Why?
| | Infant, Newborn | 14 | 2020 | 6079 | 0.150 |
Why?
| | Isomerases | 3 | 1988 | 8 | 0.150 |
Why?
| | Carnitine | 2 | 1990 | 84 | 0.150 |
Why?
| | Vitamin B 6 Deficiency | 3 | 2011 | 6 | 0.150 |
Why?
| | Sarcosine | 6 | 2012 | 10 | 0.150 |
Why?
| | Risk Factors | 15 | 2017 | 10388 | 0.150 |
Why?
| | Hemophilia B | 2 | 2003 | 61 | 0.150 |
Why?
| | Homozygote | 2 | 2015 | 203 | 0.140 |
Why?
| | Adolescent | 28 | 2020 | 21513 | 0.140 |
Why?
| | Liver Diseases | 2 | 2020 | 315 | 0.140 |
Why?
| | Chromatography, Liquid | 4 | 2011 | 433 | 0.140 |
Why?
| | Genotype | 8 | 2015 | 1916 | 0.140 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1242 | 0.140 |
Why?
| | Georgia | 5 | 2013 | 86 | 0.140 |
Why?
| | Infant | 14 | 2015 | 9465 | 0.140 |
Why?
| | Young Adult | 17 | 2020 | 13209 | 0.140 |
Why?
| | Mass Spectrometry | 4 | 2017 | 739 | 0.140 |
Why?
| | Geriatric Assessment | 4 | 2013 | 224 | 0.140 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 46 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 69 | 0.140 |
Why?
| | Racemases and Epimerases | 2 | 2006 | 11 | 0.140 |
Why?
| | Lymphoma, AIDS-Related | 2 | 1996 | 14 | 0.130 |
Why?
| | Genetic Variation | 2 | 2015 | 991 | 0.130 |
Why?
| | Thymidine Monophosphate | 3 | 2013 | 4 | 0.130 |
Why?
| | Phosphatidylcholines | 5 | 2013 | 147 | 0.130 |
Why?
| | Folate Receptor 2 | 1 | 2017 | 9 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2017 | 137 | 0.130 |
Why?
| | Methyltransferases | 5 | 2008 | 78 | 0.130 |
Why?
| | DNA, Mitochondrial | 3 | 2021 | 200 | 0.130 |
Why?
| | ROC Curve | 2 | 2011 | 554 | 0.130 |
Why?
| | Child, Preschool | 17 | 2020 | 11074 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2018 | 217 | 0.130 |
Why?
| | Hematinics | 2 | 2006 | 22 | 0.120 |
Why?
| | Lung | 5 | 2012 | 4060 | 0.120 |
Why?
| | Thromboembolism | 2 | 2015 | 119 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 528 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2015 | 2189 | 0.120 |
Why?
| | Crosses, Genetic | 2 | 2013 | 137 | 0.120 |
Why?
| | Propionates | 3 | 2017 | 39 | 0.120 |
Why?
| | Diabetic Nephropathies | 1 | 1999 | 294 | 0.120 |
Why?
| | Hydroxocobalamin | 3 | 1990 | 26 | 0.120 |
Why?
| | Alleles | 5 | 2009 | 891 | 0.120 |
Why?
| | Stomach | 1 | 1996 | 110 | 0.120 |
Why?
| | Genome | 1 | 2018 | 300 | 0.120 |
Why?
| | Neoplasms, Experimental | 2 | 2017 | 176 | 0.120 |
Why?
| | Linear Models | 5 | 2010 | 849 | 0.120 |
Why?
| | Glycine N-Methyltransferase | 3 | 2011 | 4 | 0.120 |
Why?
| | Weight Gain | 2 | 2016 | 519 | 0.120 |
Why?
| | Phospholipids | 1 | 2017 | 223 | 0.120 |
Why?
| | Alcoholism | 2 | 2020 | 807 | 0.120 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 570 | 0.120 |
Why?
| | Keratinocytes | 2 | 2018 | 249 | 0.120 |
Why?
| | Pilot Projects | 3 | 2020 | 1710 | 0.120 |
Why?
| | Double-Blind Method | 7 | 2015 | 1993 | 0.120 |
Why?
| | Age Factors | 6 | 2010 | 3295 | 0.120 |
Why?
| | Thymidylate Synthase | 2 | 2011 | 12 | 0.120 |
Why?
| | Choline Deficiency | 3 | 2012 | 11 | 0.110 |
Why?
| | Hemophilia A | 2 | 1996 | 139 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 38 | 0.110 |
Why?
| | Milk, Human | 2 | 2015 | 158 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 15 | 0.110 |
Why?
| | RNA, Messenger | 6 | 2017 | 2833 | 0.110 |
Why?
| | Dietary Fats | 1 | 2016 | 304 | 0.110 |
Why?
| | Micronutrients | 1 | 2015 | 92 | 0.110 |
Why?
| | DNA Methylation | 4 | 2018 | 643 | 0.110 |
Why?
| | Placenta | 3 | 2017 | 750 | 0.110 |
Why?
| | Hemoglobins, Abnormal | 1 | 1994 | 11 | 0.110 |
Why?
| | Energy Intake | 2 | 2015 | 485 | 0.110 |
Why?
| | Child | 16 | 2020 | 21935 | 0.110 |
Why?
| | Cyanosis | 1 | 1994 | 16 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 860 | 0.110 |
Why?
| | Cross-Sectional Studies | 7 | 2010 | 5472 | 0.110 |
Why?
| | Blotting, Western | 5 | 2014 | 1226 | 0.110 |
Why?
| | Milk | 1 | 2014 | 124 | 0.110 |
Why?
| | Paresthesia | 2 | 2013 | 15 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 630 | 0.100 |
Why?
| | Colitis | 2 | 2019 | 266 | 0.100 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 233 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2014 | 170 | 0.100 |
Why?
| | Time Factors | 7 | 2006 | 6828 | 0.100 |
Why?
| | Infant Nutrition Disorders | 1 | 2013 | 11 | 0.100 |
Why?
| | Child Nutrition Disorders | 1 | 2013 | 20 | 0.100 |
Why?
| | Lipid Metabolism | 1 | 2016 | 518 | 0.100 |
Why?
| | Malonates | 3 | 1990 | 8 | 0.100 |
Why?
| | Analysis of Variance | 5 | 2011 | 1316 | 0.100 |
Why?
| | Interleukin-1beta | 2 | 2011 | 372 | 0.100 |
Why?
| | Women's Health | 3 | 2015 | 372 | 0.100 |
Why?
| | Chloroflexi | 1 | 2012 | 12 | 0.100 |
Why?
| | Maternal-Fetal Exchange | 1 | 2013 | 165 | 0.100 |
Why?
| | Papillomavirus Infections | 2 | 2018 | 325 | 0.100 |
Why?
| | Apolipoproteins A | 1 | 2012 | 19 | 0.100 |
Why?
| | Hemoglobins | 3 | 2011 | 353 | 0.100 |
Why?
| | Aminohydrolases | 1 | 2012 | 4 | 0.100 |
Why?
| | DNA Mutational Analysis | 3 | 2009 | 399 | 0.100 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 18 | 0.100 |
Why?
| | Apolipoprotein A-I | 1 | 2012 | 30 | 0.100 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 25 | 0.100 |
Why?
| | Injections | 1 | 2013 | 183 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 2 | 2011 | 889 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2607 | 0.090 |
Why?
| | Multienzyme Complexes | 1 | 2012 | 68 | 0.090 |
Why?
| | Fibroblasts | 6 | 2021 | 996 | 0.090 |
Why?
| | Pyridoxine | 3 | 1996 | 36 | 0.090 |
Why?
| | Logistic Models | 4 | 2013 | 2074 | 0.090 |
Why?
| | Bone Density | 1 | 2015 | 489 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2013 | 170 | 0.090 |
Why?
| | Prospective Studies | 12 | 2013 | 7604 | 0.090 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 288 | 0.090 |
Why?
| | Neurogenesis | 1 | 2013 | 149 | 0.090 |
Why?
| | Memory | 1 | 2013 | 248 | 0.090 |
Why?
| | Cognition | 2 | 2013 | 1153 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 2009 | 527 | 0.090 |
Why?
| | Oxidative Stress | 4 | 2019 | 1317 | 0.090 |
Why?
| | Vitamins | 3 | 2007 | 185 | 0.090 |
Why?
| | Cell Nucleus | 2 | 2011 | 620 | 0.090 |
Why?
| | Inflammation | 3 | 2019 | 2837 | 0.090 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2008 | 68 | 0.090 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2011 | 173 | 0.090 |
Why?
| | Hydrops Fetalis | 1 | 2010 | 13 | 0.090 |
Why?
| | Mutation, Missense | 4 | 2009 | 341 | 0.090 |
Why?
| | Nutritional Requirements | 2 | 2010 | 78 | 0.090 |
Why?
| | Superoxide Dismutase | 1 | 1993 | 346 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 976 | 0.080 |
Why?
| | Cell Line | 4 | 2017 | 2847 | 0.080 |
Why?
| | Polymerase Chain Reaction | 3 | 2009 | 1062 | 0.080 |
Why?
| | Coenzyme A | 1 | 1990 | 7 | 0.080 |
Why?
| | RNA-Binding Proteins | 3 | 2017 | 422 | 0.080 |
Why?
| | Lactams | 1 | 1990 | 20 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 1946 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 228 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1266 | 0.080 |
Why?
| | Creatinine | 4 | 2011 | 499 | 0.080 |
Why?
| | Hematocrit | 4 | 2002 | 96 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 265 | 0.080 |
Why?
| | Mice, Nude | 3 | 2018 | 698 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 255 | 0.080 |
Why?
| | Treatment Outcome | 8 | 2013 | 10811 | 0.080 |
Why?
| | Leukocytes | 2 | 2015 | 311 | 0.080 |
Why?
| | Siblings | 1 | 2010 | 228 | 0.080 |
Why?
| | Endothelium, Vascular | 2 | 2006 | 927 | 0.080 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 257 | 0.080 |
Why?
| | Educational Status | 2 | 2003 | 470 | 0.080 |
Why?
| | Gastrointestinal Contents | 1 | 2009 | 8 | 0.080 |
Why?
| | Neuropsychological Tests | 3 | 2013 | 1023 | 0.080 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1502 | 0.080 |
Why?
| | Antibodies, Bacterial | 1 | 2010 | 146 | 0.080 |
Why?
| | Kidney | 2 | 2007 | 1468 | 0.080 |
Why?
| | Formates | 1 | 2008 | 13 | 0.080 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2008 | 6 | 0.080 |
Why?
| | Reduced Folate Carrier Protein | 1 | 2008 | 10 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 658 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 415 | 0.070 |
Why?
| | Deuterium | 3 | 2015 | 99 | 0.070 |
Why?
| | Amino Acid Isomerases | 1 | 1988 | 1 | 0.070 |
Why?
| | Intramolecular Transferases | 1 | 1988 | 3 | 0.070 |
Why?
| | Homeostasis | 2 | 2020 | 621 | 0.070 |
Why?
| | Fatty Liver | 2 | 2010 | 243 | 0.070 |
Why?
| | Biological Availability | 2 | 2010 | 148 | 0.070 |
Why?
| | Recurrence | 1 | 2011 | 1060 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2111 | 0.070 |
Why?
| | Oxygen | 1 | 1993 | 931 | 0.070 |
Why?
| | Hippocampus | 1 | 2013 | 895 | 0.070 |
Why?
| | Lipids | 1 | 2012 | 672 | 0.070 |
Why?
| | Leucine | 1 | 1988 | 111 | 0.070 |
Why?
| | Folate Receptors, GPI-Anchored | 2 | 2005 | 5 | 0.070 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2007 | 54 | 0.070 |
Why?
| | Parity | 1 | 2008 | 126 | 0.070 |
Why?
| | Cytoplasm | 1 | 2008 | 274 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1250 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2009 | 2486 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2008 | 1289 | 0.070 |
Why?
| | Regression Analysis | 2 | 2000 | 1024 | 0.070 |
Why?
| | Muscle, Skeletal | 2 | 2007 | 1724 | 0.070 |
Why?
| | Cobalt | 3 | 2014 | 52 | 0.070 |
Why?
| | Obesity | 1 | 2020 | 2992 | 0.070 |
Why?
| | Molecular Sequence Data | 5 | 2012 | 2900 | 0.070 |
Why?
| | Succinates | 4 | 1991 | 22 | 0.070 |
Why?
| | Pregnancy Trimester, Third | 2 | 2020 | 114 | 0.070 |
Why?
| | Fibrinogens, Abnormal | 1 | 2006 | 4 | 0.060 |
Why?
| | Thrombin Time | 1 | 2006 | 12 | 0.060 |
Why?
| | Afibrinogenemia | 1 | 2006 | 6 | 0.060 |
Why?
| | Succinic Acid | 4 | 1991 | 37 | 0.060 |
Why?
| | Base Sequence | 4 | 2015 | 2181 | 0.060 |
Why?
| | Iron | 2 | 2008 | 313 | 0.060 |
Why?
| | Diagnosis, Differential | 4 | 2006 | 1483 | 0.060 |
Why?
| | Cobamides | 1 | 2006 | 20 | 0.060 |
Why?
| | Cardiotonic Agents | 1 | 2006 | 124 | 0.060 |
Why?
| | Mitochondria | 3 | 2021 | 948 | 0.060 |
Why?
| | Smoking | 2 | 2012 | 1627 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2001 | 2531 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 204 | 0.060 |
Why?
| | Social Class | 2 | 2005 | 282 | 0.060 |
Why?
| | Dextran Sulfate | 2 | 2019 | 83 | 0.060 |
Why?
| | Homocystine | 1 | 2005 | 1 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 1999 | 230 | 0.060 |
Why?
| | von Willebrand Factor | 2 | 2006 | 80 | 0.060 |
Why?
| | Oncogene Proteins, Viral | 2 | 2018 | 22 | 0.060 |
Why?
| | Severity of Illness Index | 5 | 2011 | 2828 | 0.060 |
Why?
| | Disulfides | 2 | 2008 | 107 | 0.060 |
Why?
| | Recommended Dietary Allowances | 2 | 2015 | 18 | 0.060 |
Why?
| | Acidosis | 1 | 2006 | 101 | 0.060 |
Why?
| | Transfection | 2 | 2006 | 945 | 0.060 |
Why?
| | Brain Edema | 2 | 2003 | 61 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2011 | 1164 | 0.060 |
Why?
| | Fetus | 2 | 2012 | 806 | 0.060 |
Why?
| | Food Services | 1 | 2005 | 21 | 0.060 |
Why?
| | Hyperoxia | 1 | 2005 | 90 | 0.060 |
Why?
| | Kidney Diseases | 2 | 2007 | 408 | 0.060 |
Why?
| | Zinc | 1 | 2008 | 297 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1587 | 0.060 |
Why?
| | Mass Screening | 3 | 2002 | 1287 | 0.060 |
Why?
| | Epidemiologic Methods | 1 | 2005 | 97 | 0.060 |
Why?
| | Gene Expression | 3 | 2018 | 1502 | 0.060 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2018 | 257 | 0.060 |
Why?
| | Apoptosis | 2 | 2012 | 2553 | 0.050 |
Why?
| | Brain | 5 | 2012 | 2668 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1276 | 0.050 |
Why?
| | Carotid Stenosis | 1 | 2005 | 91 | 0.050 |
Why?
| | Diet, Vegetarian | 1 | 2004 | 8 | 0.050 |
Why?
| | Hemorrhage | 2 | 2006 | 722 | 0.050 |
Why?
| | Indicator Dilution Techniques | 1 | 2003 | 11 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 623 | 0.050 |
Why?
| | Menopause | 1 | 2007 | 320 | 0.050 |
Why?
| | Postoperative Complications | 1 | 1996 | 2654 | 0.050 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2006 | 199 | 0.050 |
Why?
| | 5' Untranslated Regions | 1 | 2004 | 58 | 0.050 |
Why?
| | Liver Cirrhosis | 2 | 2010 | 316 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2671 | 0.050 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2008 | 394 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 164 | 0.050 |
Why?
| | Fasting | 5 | 2004 | 281 | 0.050 |
Why?
| | Arginine | 1 | 2005 | 271 | 0.050 |
Why?
| | Mental Disorders | 3 | 1998 | 1077 | 0.050 |
Why?
| | Sex Factors | 3 | 2010 | 2071 | 0.050 |
Why?
| | Testosterone | 1 | 2007 | 409 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2008 | 1096 | 0.050 |
Why?
| | Factor IX | 1 | 2003 | 48 | 0.050 |
Why?
| | Nutritional Support | 1 | 2003 | 34 | 0.050 |
Why?
| | Protein Binding | 2 | 2012 | 2224 | 0.050 |
Why?
| | Infant Food | 1 | 2003 | 65 | 0.050 |
Why?
| | Smoke | 1 | 2004 | 141 | 0.050 |
Why?
| | Lyases | 1 | 2002 | 12 | 0.050 |
Why?
| | Kinetics | 6 | 2007 | 1670 | 0.050 |
Why?
| | Connective Tissue | 1 | 2002 | 36 | 0.050 |
Why?
| | Mutagenesis, Insertional | 2 | 2012 | 65 | 0.050 |
Why?
| | Brachial Artery | 2 | 2019 | 205 | 0.050 |
Why?
| | Glutamates | 1 | 2002 | 59 | 0.050 |
Why?
| | Cell Line, Tumor | 3 | 2005 | 3412 | 0.050 |
Why?
| | HeLa Cells | 1 | 2004 | 636 | 0.050 |
Why?
| | Guanine | 1 | 2002 | 79 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 298 | 0.050 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 15 | 0.050 |
Why?
| | Metalloendopeptidases | 1 | 2001 | 62 | 0.050 |
Why?
| | Vascular Diseases | 3 | 2004 | 243 | 0.050 |
Why?
| | Pyridoxal Phosphate | 2 | 2011 | 24 | 0.050 |
Why?
| | Methotrexate | 2 | 2015 | 260 | 0.050 |
Why?
| | Phenotype | 4 | 2014 | 3196 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 5778 | 0.040 |
Why?
| | Birth Weight | 1 | 2004 | 516 | 0.040 |
Why?
| | Down-Regulation | 1 | 2004 | 657 | 0.040 |
Why?
| | Pregnancy Outcome | 2 | 2020 | 416 | 0.040 |
Why?
| | Molecular Weight | 5 | 1988 | 335 | 0.040 |
Why?
| | Malonyl Coenzyme A | 3 | 1990 | 5 | 0.040 |
Why?
| | Antigens, CD | 2 | 2001 | 521 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2000 | 8 | 0.040 |
Why?
| | Models, Biological | 4 | 2012 | 1783 | 0.040 |
Why?
| | New York | 2 | 2015 | 126 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 199 | 0.040 |
Why?
| | Papio | 1 | 2000 | 94 | 0.040 |
Why?
| | Citrates | 3 | 1998 | 44 | 0.040 |
Why?
| | Anemia, Macrocytic | 1 | 2000 | 4 | 0.040 |
Why?
| | Case-Control Studies | 5 | 2010 | 3556 | 0.040 |
Why?
| | Neurocognitive Disorders | 2 | 1992 | 26 | 0.040 |
Why?
| | Coronary Artery Disease | 1 | 2006 | 698 | 0.040 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2000 | 84 | 0.040 |
Why?
| | Sampling Studies | 1 | 2000 | 99 | 0.040 |
Why?
| | Diabetic Neuropathies | 1 | 2001 | 94 | 0.040 |
Why?
| | Genetic Testing | 1 | 2003 | 460 | 0.040 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2001 | 271 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1994 | 597 | 0.040 |
Why?
| | Oncogenes | 1 | 2020 | 116 | 0.040 |
Why?
| | Odds Ratio | 3 | 2002 | 1070 | 0.040 |
Why?
| | Parenteral Nutrition | 1 | 2000 | 107 | 0.040 |
Why?
| | Blotting, Northern | 3 | 2007 | 201 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1353 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 1996 | 266 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 232 | 0.040 |
Why?
| | Cecum | 1 | 2019 | 33 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 124 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2000 | 128 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 92 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2003 | 413 | 0.040 |
Why?
| | Species Specificity | 2 | 2007 | 585 | 0.040 |
Why?
| | Stroke | 2 | 2005 | 1120 | 0.040 |
Why?
| | Reticulocyte Count | 2 | 2000 | 6 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 1999 | 160 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 345 | 0.040 |
Why?
| | Pancytopenia | 1 | 1999 | 8 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2019 | 56 | 0.040 |
Why?
| | Metabolomics | 2 | 2017 | 678 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2000 | 216 | 0.040 |
Why?
| | Income | 1 | 1999 | 202 | 0.040 |
Why?
| | RNA | 2 | 2004 | 921 | 0.040 |
Why?
| | Albuminuria | 1 | 1999 | 185 | 0.040 |
Why?
| | Oligodendroglia | 1 | 2000 | 179 | 0.040 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 11 | 0.040 |
Why?
| | Nutrition Policy | 2 | 2010 | 61 | 0.040 |
Why?
| | Cross-Over Studies | 2 | 2014 | 564 | 0.040 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 43 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 285 | 0.040 |
Why?
| | Pedigree | 2 | 2001 | 514 | 0.040 |
Why?
| | Tissue Distribution | 2 | 2011 | 332 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 367 | 0.030 |
Why?
| | Exons | 2 | 2011 | 355 | 0.030 |
Why?
| | Central Nervous System Diseases | 1 | 1998 | 69 | 0.030 |
Why?
| | Aspartate Aminotransferases | 2 | 2011 | 90 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2001 | 778 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 141 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2010 | 145 | 0.030 |
Why?
| | Cytosol | 1 | 2017 | 226 | 0.030 |
Why?
| | Alcohol Drinking | 2 | 2001 | 828 | 0.030 |
Why?
| | History, 20th Century | 2 | 2015 | 325 | 0.030 |
Why?
| | Angina Pectoris | 1 | 1997 | 65 | 0.030 |
Why?
| | Alanine Transaminase | 2 | 2011 | 157 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2016 | 36 | 0.030 |
Why?
| | Chronic Disease | 2 | 2011 | 1793 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 418 | 0.030 |
Why?
| | United States | 3 | 2020 | 14841 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2005 | 810 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2000 | 122 | 0.030 |
Why?
| | HIV Infections | 2 | 2001 | 2836 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2010 | 303 | 0.030 |
Why?
| | Denmark | 1 | 2015 | 46 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2012 | 4193 | 0.030 |
Why?
| | Sulfaquinoxaline | 1 | 2015 | 1 | 0.030 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 746 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 5 | 2006 | 3566 | 0.030 |
Why?
| | Food, Formulated | 1 | 2015 | 14 | 0.030 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1996 | 87 | 0.030 |
Why?
| | Hematologic Diseases | 1 | 1996 | 62 | 0.030 |
Why?
| | Carbon Cycle | 1 | 2015 | 18 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 380 | 0.030 |
Why?
| | Body Weight | 2 | 2011 | 985 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2015 | 90 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 1997 | 234 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 1995 | 80 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1622 | 0.030 |
Why?
| | Hyaline Membrane Disease | 1 | 1994 | 20 | 0.030 |
Why?
| | Omasum | 1 | 2014 | 1 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2475 | 0.030 |
Why?
| | Parenteral Nutrition, Total | 1 | 1994 | 26 | 0.030 |
Why?
| | Histones | 1 | 2020 | 636 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2015 | 64 | 0.030 |
Why?
| | Fermentation | 1 | 2014 | 26 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 289 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 36 | 0.030 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.030 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 8 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 199 | 0.030 |
Why?
| | Family Health | 2 | 2006 | 196 | 0.030 |
Why?
| | Intrinsic Factor | 2 | 2010 | 2 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2018 | 427 | 0.030 |
Why?
| | Larva | 1 | 2015 | 226 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 350 | 0.030 |
Why?
| | Renal Insufficiency | 2 | 1993 | 162 | 0.030 |
Why?
| | Isoelectric Focusing | 1 | 1994 | 34 | 0.030 |
Why?
| | Electrophoresis | 1 | 1994 | 32 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 465 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 92 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 213 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 72 | 0.030 |
Why?
| | Radioisotope Dilution Technique | 3 | 1988 | 14 | 0.030 |
Why?
| | Myocardial Infarction | 2 | 2004 | 1046 | 0.030 |
Why?
| | Body Patterning | 1 | 2014 | 132 | 0.030 |
Why?
| | Chromatography, Affinity | 3 | 1988 | 88 | 0.030 |
Why?
| | Animal Feed | 2 | 2009 | 53 | 0.030 |
Why?
| | Neural Crest | 1 | 2014 | 118 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5131 | 0.030 |
Why?
| | Mammals | 1 | 2015 | 283 | 0.030 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1809 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.030 |
Why?
| | Coronary Disease | 1 | 1996 | 385 | 0.030 |
Why?
| | Blood Glucose | 2 | 2016 | 2186 | 0.030 |
Why?
| | RNA, Viral | 2 | 2012 | 656 | 0.030 |
Why?
| | Hydrolysis | 1 | 2013 | 177 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1994 | 137 | 0.030 |
Why?
| | Litter Size | 1 | 2013 | 17 | 0.030 |
Why?
| | Dentate Gyrus | 1 | 2013 | 37 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 346 | 0.030 |
Why?
| | Avitaminosis | 2 | 2007 | 7 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 390 | 0.030 |
Why?
| | Receptors, CCR2 | 1 | 2013 | 40 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1990 | 265 | 0.020 |
Why?
| | Tetrachloroethylene | 1 | 2012 | 4 | 0.020 |
Why?
| | Trichloroethylene | 1 | 2012 | 8 | 0.020 |
Why?
| | Stroke Volume | 1 | 1996 | 612 | 0.020 |
Why?
| | Ethylenes | 1 | 2012 | 9 | 0.020 |
Why?
| | Tunicamycin | 1 | 2012 | 12 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2013 | 316 | 0.020 |
Why?
| | Cell Differentiation | 2 | 2014 | 1991 | 0.020 |
Why?
| | Eating | 1 | 2015 | 380 | 0.020 |
Why?
| | Neurologic Examination | 1 | 1992 | 110 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 1996 | 534 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2012 | 103 | 0.020 |
Why?
| | Lipotropic Agents | 1 | 2012 | 5 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2012 | 67 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2012 | 74 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 19 | 0.020 |
Why?
| | Biodegradation, Environmental | 1 | 2012 | 84 | 0.020 |
Why?
| | Sarcoma, Kaposi | 1 | 1993 | 81 | 0.020 |
Why?
| | Chondrocytes | 1 | 2014 | 212 | 0.020 |
Why?
| | Embryo Loss | 1 | 2012 | 4 | 0.020 |
Why?
| | Patient Selection | 1 | 1996 | 696 | 0.020 |
Why?
| | HIV Seropositivity | 1 | 1993 | 125 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.020 |
Why?
| | Postpartum Period | 1 | 2015 | 340 | 0.020 |
Why?
| | Hypoxanthine | 1 | 2012 | 11 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2016 | 635 | 0.020 |
Why?
| | Carcinoma, Basal Cell | 1 | 1993 | 75 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 353 | 0.020 |
Why?
| | Catalase | 1 | 2012 | 130 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2013 | 283 | 0.020 |
Why?
| | Lipoproteins | 1 | 2013 | 168 | 0.020 |
Why?
| | S Phase | 1 | 2011 | 77 | 0.020 |
Why?
| | Radioligand Assay | 1 | 2011 | 48 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2013 | 247 | 0.020 |
Why?
| | Ferritins | 1 | 2011 | 64 | 0.020 |
Why?
| | Necrosis | 1 | 2012 | 246 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 23 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2011 | 124 | 0.020 |
Why?
| | Microbiological Techniques | 1 | 2011 | 30 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2001 | 43 | 0.020 |
Why?
| | Ethanol | 1 | 1996 | 608 | 0.020 |
Why?
| | Breast Feeding | 1 | 2015 | 440 | 0.020 |
Why?
| | Capsid Proteins | 1 | 2012 | 94 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 269 | 0.020 |
Why?
| | Chromatography, Ion Exchange | 2 | 1988 | 55 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2011 | 183 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 177 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 697 | 0.020 |
Why?
| | Epithelium | 1 | 2012 | 313 | 0.020 |
Why?
| | Chromatography, Gel | 2 | 1988 | 127 | 0.020 |
Why?
| | Neuroblastoma | 1 | 2012 | 160 | 0.020 |
Why?
| | Nitrous Oxide | 1 | 1991 | 33 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 362 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 58 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 88 | 0.020 |
Why?
| | Mitochondrial Diseases | 1 | 2011 | 91 | 0.020 |
Why?
| | Transgenes | 1 | 2011 | 180 | 0.020 |
Why?
| | Renal Dialysis | 1 | 1995 | 435 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.020 |
Why?
| | Gastrins | 1 | 1990 | 8 | 0.020 |
Why?
| | Protein Conformation | 1 | 1994 | 934 | 0.020 |
Why?
| | Serum Albumin | 1 | 2011 | 150 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 186 | 0.020 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2010 | 6 | 0.020 |
Why?
| | Peroxidase | 1 | 2011 | 175 | 0.020 |
Why?
| | Placebos | 2 | 2005 | 199 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 309 | 0.020 |
Why?
| | Macromolecular Substances | 2 | 1988 | 229 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 547 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 1990 | 73 | 0.020 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2010 | 17 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 119 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2004 | 2526 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 150 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1990 | 14 | 0.020 |
Why?
| | Bilirubin | 1 | 1990 | 97 | 0.020 |
Why?
| | Aorta | 1 | 2013 | 417 | 0.020 |
Why?
| | Hypertension | 1 | 1999 | 1295 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 594 | 0.020 |
Why?
| | Monocytes | 1 | 2013 | 563 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 967 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 499 | 0.020 |
Why?
| | Fear | 1 | 2013 | 338 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 513 | 0.020 |
Why?
| | Dairying | 1 | 2009 | 7 | 0.020 |
Why?
| | Purines | 1 | 2011 | 176 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2139 | 0.020 |
Why?
| | Hemostasis | 1 | 2010 | 82 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 1991 | 570 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2010 | 42 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 730 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 120 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 767 | 0.020 |
Why?
| | Nigeria | 1 | 2009 | 23 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 363 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2011 | 302 | 0.020 |
Why?
| | Burkitt Lymphoma | 1 | 1989 | 60 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 410 | 0.020 |
Why?
| | Osteosarcoma | 1 | 1989 | 74 | 0.020 |
Why?
| | Acetylcarnitine | 1 | 1988 | 5 | 0.020 |
Why?
| | Peroxides | 1 | 2008 | 19 | 0.020 |
Why?
| | Muscles | 1 | 1990 | 326 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 684 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 1142 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2012 | 364 | 0.020 |
Why?
| | Bacteria | 1 | 2015 | 858 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 78 | 0.020 |
Why?
| | Microchemistry | 1 | 1988 | 20 | 0.020 |
Why?
| | Isoleucine | 1 | 1988 | 15 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1992 | 546 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 1994 | 560 | 0.020 |
Why?
| | Health Status Disparities | 1 | 2011 | 289 | 0.020 |
Why?
| | Silicon | 1 | 1988 | 16 | 0.020 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 173 | 0.020 |
Why?
| | Predictive Value of Tests | 3 | 2000 | 2031 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 1988 | 36 | 0.020 |
Why?
| | Catalytic Domain | 1 | 2009 | 207 | 0.020 |
Why?
| | Ethiopia | 1 | 2008 | 41 | 0.020 |
Why?
| | Multivariate Analysis | 2 | 2002 | 1509 | 0.020 |
Why?
| | Tritium | 1 | 1988 | 76 | 0.020 |
Why?
| | Thiolester Hydrolases | 1 | 1988 | 13 | 0.020 |
Why?
| | Ileum | 1 | 2009 | 119 | 0.020 |
Why?
| | Pyrimidines | 1 | 2011 | 470 | 0.020 |
Why?
| | Haplotypes | 1 | 2010 | 494 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2011 | 532 | 0.020 |
Why?
| | Zea mays | 1 | 2008 | 41 | 0.020 |
Why?
| | Valine | 1 | 1988 | 82 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1129 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2008 | 240 | 0.020 |
Why?
| | Embryonic Development | 1 | 2008 | 119 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2007 | 26 | 0.020 |
Why?
| | Fibrosis | 1 | 2010 | 552 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.020 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2007 | 5 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2009 | 232 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 654 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2007 | 158 | 0.020 |
Why?
| | Infusions, Intravenous | 2 | 2003 | 413 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 778 | 0.020 |
Why?
| | Creatine | 1 | 2007 | 57 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2006 | 67 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 1998 | 129 | 0.020 |
Why?
| | Prenatal Care | 1 | 2009 | 294 | 0.020 |
Why?
| | von Willebrand Diseases | 1 | 2006 | 27 | 0.020 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2006 | 53 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 289 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 588 | 0.020 |
Why?
| | Gene Frequency | 1 | 2007 | 521 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2008 | 321 | 0.020 |
Why?
| | Dicarboxylic Acids | 1 | 1985 | 9 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2010 | 405 | 0.020 |
Why?
| | Rabbits | 1 | 2007 | 794 | 0.020 |
Why?
| | Muscular Diseases | 1 | 2006 | 114 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 600 | 0.010 |
Why?
| | Edible Grain | 1 | 2005 | 49 | 0.010 |
Why?
| | Croatia | 1 | 2005 | 5 | 0.010 |
Why?
| | Transaminases | 1 | 2005 | 24 | 0.010 |
Why?
| | Dipeptides | 1 | 2005 | 50 | 0.010 |
Why?
| | HIV-1 | 2 | 2001 | 864 | 0.010 |
Why?
| | Creatine Kinase | 1 | 2005 | 79 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 86 | 0.010 |
Why?
| | New York City | 1 | 2004 | 85 | 0.010 |
Why?
| | RNA Interference | 1 | 2006 | 469 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2011 | 15657 | 0.010 |
Why?
| | tert-Butylhydroperoxide | 1 | 2004 | 10 | 0.010 |
Why?
| | Metals | 1 | 1985 | 136 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1272 | 0.010 |
Why?
| | Apolipoprotein E4 | 1 | 2004 | 37 | 0.010 |
Why?
| | Neurons | 1 | 2013 | 1590 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 955 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1570 | 0.010 |
Why?
| | Psychological Tests | 1 | 2004 | 140 | 0.010 |
Why?
| | Depression | 1 | 2013 | 1397 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2005 | 413 | 0.010 |
Why?
| | Hemostasis, Surgical | 1 | 2003 | 22 | 0.010 |
Why?
| | Myelin Sheath | 1 | 2005 | 167 | 0.010 |
Why?
| | Hepatocytes | 1 | 2004 | 220 | 0.010 |
Why?
| | Inactivation, Metabolic | 1 | 2002 | 11 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2004 | 177 | 0.010 |
Why?
| | Colorado | 1 | 1992 | 4565 | 0.010 |
Why?
| | Enzyme Stability | 1 | 2002 | 70 | 0.010 |
Why?
| | Pemetrexed | 1 | 2002 | 33 | 0.010 |
Why?
| | Cricetulus | 1 | 2002 | 109 | 0.010 |
Why?
| | Drug Contamination | 1 | 2002 | 53 | 0.010 |
Why?
| | Brain Death | 1 | 2002 | 46 | 0.010 |
Why?
| | Citrate (si)-Synthase | 2 | 1993 | 60 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 611 | 0.010 |
Why?
| | Autoantibodies | 1 | 2010 | 1496 | 0.010 |
Why?
| | Physical Chromosome Mapping | 1 | 2001 | 20 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2007 | 762 | 0.010 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2001 | 41 | 0.010 |
Why?
| | Hepatomegaly | 1 | 2001 | 4 | 0.010 |
Why?
| | Carcinoma | 1 | 2004 | 240 | 0.010 |
Why?
| | Computational Biology | 1 | 2006 | 644 | 0.010 |
Why?
| | Radiography | 1 | 2004 | 822 | 0.010 |
Why?
| | Transcription Factors | 1 | 2010 | 1719 | 0.010 |
Why?
| | Vasodilation | 1 | 2005 | 499 | 0.010 |
Why?
| | Hypertension, Renal | 1 | 2001 | 16 | 0.010 |
Why?
| | Treatment Refusal | 1 | 2002 | 89 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2003 | 146 | 0.010 |
Why?
| | Coffee | 1 | 2001 | 17 | 0.010 |
Why?
| | Tea | 1 | 2001 | 21 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 198 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 2007 | 708 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 786 | 0.010 |
Why?
| | Chromatography, Gas | 1 | 2000 | 33 | 0.010 |
Why?
| | Bone Marrow Diseases | 1 | 2000 | 19 | 0.010 |
Why?
| | Cell Survival | 1 | 2004 | 1120 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1738 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 523 | 0.010 |
Why?
| | Platelet Count | 1 | 2000 | 86 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2000 | 110 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2002 | 347 | 0.010 |
Why?
| | Ultrasonography | 1 | 2004 | 759 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2007 | 871 | 0.010 |
Why?
| | Kynurenine | 1 | 2000 | 114 | 0.010 |
Why?
| | Probability | 1 | 2000 | 304 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2000 | 329 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2000 | 431 | 0.010 |
Why?
| | Hypersplenism | 1 | 1999 | 8 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2000 | 455 | 0.010 |
Why?
| | Tryptophan | 1 | 2000 | 183 | 0.010 |
Why?
| | Zimbabwe | 1 | 1999 | 58 | 0.010 |
Why?
| | Anemia, Aplastic | 1 | 1999 | 38 | 0.010 |
Why?
| | Viral Load | 1 | 2000 | 466 | 0.010 |
Why?
| | Life Style | 1 | 2001 | 490 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2804 | 0.010 |
Why?
| | Chromatography, DEAE-Cellulose | 2 | 1988 | 13 | 0.010 |
Why?
| | Carbon Radioisotopes | 2 | 1988 | 34 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 815 | 0.010 |
Why?
| | Indicators and Reagents | 2 | 1988 | 106 | 0.010 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2000 | 250 | 0.010 |
Why?
| | Drug Overdose | 1 | 2002 | 347 | 0.010 |
Why?
| | Demyelinating Diseases | 1 | 1998 | 85 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2000 | 1066 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2001 | 494 | 0.010 |
Why?
| | Leukemia | 1 | 1999 | 240 | 0.010 |
Why?
| | Genes | 1 | 1996 | 230 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1996 | 3 | 0.010 |
Why?
| | Theophylline | 1 | 1996 | 67 | 0.010 |
Why?
| | Thymine Nucleotides | 1 | 1996 | 16 | 0.010 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 1996 | 53 | 0.010 |
Why?
| | Diet Surveys | 1 | 1996 | 95 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1996 | 82 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2003 | 758 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1007 | 0.010 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1996 | 127 | 0.010 |
Why?
| | Age of Onset | 1 | 1996 | 518 | 0.010 |
Why?
| | Bronchodilator Agents | 1 | 1996 | 252 | 0.010 |
Why?
| | Autopsy | 1 | 1994 | 95 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1994 | 173 | 0.010 |
Why?
| | Cell Division | 1 | 1996 | 794 | 0.010 |
Why?
| | Chromatography | 1 | 1993 | 24 | 0.010 |
Why?
| | Belgium | 1 | 1993 | 13 | 0.010 |
Why?
| | Massachusetts | 1 | 1994 | 172 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 356 | 0.010 |
Why?
| | Netherlands | 1 | 1993 | 88 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1993 | 96 | 0.010 |
Why?
| | Swine | 1 | 1996 | 775 | 0.010 |
Why?
| | Germany | 1 | 1993 | 121 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2002 | 2426 | 0.010 |
Why?
| | Blood Chemical Analysis | 1 | 1993 | 99 | 0.010 |
Why?
| | Culture Media | 1 | 1993 | 165 | 0.010 |
Why?
| | Borohydrides | 1 | 1991 | 1 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1991 | 11 | 0.010 |
Why?
| | Plasma | 1 | 1993 | 212 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 1991 | 91 | 0.010 |
Why?
| | Glutamate Dehydrogenase | 1 | 1990 | 4 | 0.010 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 1994 | 301 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1990 | 50 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 2129 | 0.010 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 1990 | 46 | 0.010 |
Why?
| | Molecular Structure | 1 | 1991 | 489 | 0.010 |
Why?
| | Glucose | 1 | 1994 | 1020 | 0.000 |
Why?
| | Light | 1 | 1991 | 381 | 0.000 |
Why?
| | Erythrocyte Indices | 1 | 1988 | 30 | 0.000 |
Why?
| | Hypesthesia | 1 | 1988 | 17 | 0.000 |
Why?
| | Ataxia | 1 | 1988 | 44 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1990 | 696 | 0.000 |
Why?
| | Intestines | 1 | 1990 | 357 | 0.000 |
Why?
| | Celiac Disease | 1 | 1990 | 294 | 0.000 |
Why?
| | Algorithms | 1 | 1994 | 1704 | 0.000 |
Why?
| | Models, Theoretical | 1 | 1989 | 578 | 0.000 |
Why?
| | Chemistry | 1 | 1985 | 45 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1985 | 83 | 0.000 |
Why?
| | Proteins | 1 | 1990 | 1009 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 2295 | 0.000 |
Why?
|
|
Stabler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|